2022 Update: Ranking biotech's top venture capital firms


2022 Update: Ranking biotech's top venture capital firms

Published: Aug. 2022

Which venture capital firms get the best returns? Our latest STAT Report is an update of our most popular report to date, this time with 2021 data. In it, STAT’s Kate Sheridan provides a definitively ranked list of more than a dozen of the biggest names in biotech investment, including Third Rock Ventures, OrbiMed, ARCH Venture Partners, and Flagship Pioneering.

This report — the third in as many years — attempts to dig a little deeper into venture capital firms, to tease out not just which firms were best positioned before the downturn, but to look at which ones have made the best bets on the fledgling companies in which they invest — bets that have a big impact on the payouts for the venture capital firm and any of its investors. 

Review the 2021 edition of this report here.

How it works

Add this report to your cart, and then complete the checkout process. Once you have, you'll receive an email with the link to download the full report file. This report is digital-only, so you will not receive a printout.


Take a peek at what's included in this jaw-dropping report.